XML 65 R22.htm IDEA: XBRL DOCUMENT v3.19.3
Net Loss Per Share
9 Months Ended
Sep. 30, 2019
Net Loss Per Share [Abstract]  
Net Loss Per Share (14) Net Loss Per Share:

The reconciliation of the net loss per share calculation is as follows:

For the three months ended

For the nine months ended

September 30,

September 30,

($ in millions and shares in thousands, except per share amounts)

2019

2018

2019

2018

Net loss used for basic and diluted loss

per share:

Total basic net loss

attributable to Frontier common shareholders

$

(345)

$

(426)

$

(5,749)

$

(531)

Effect of loss related to dilutive stock units

-

-

-

-

Total diluted net loss

attributable to Frontier common shareholders

$

(345)

$

(426)

$

(5,749)

$

(531)

Basic loss per share:

Total weighted average shares and unvested restricted stock

awards outstanding - basic

105,372 

105,740 

105,375 

88,997 

Less: Weighted average unvested restricted stock awards

(1,237)

(2,075)

(1,344)

(1,859)

Total weighted average shares outstanding - basic

104,135 

103,665 

104,031 

87,138 

Basic net loss per share

attributable to Frontier common shareholders

$

(3.31)

$

(4.11)

$

(55.26)

$

(6.09)

Diluted loss per share:

Total weighted average shares outstanding - basic

104,135 

103,665 

104,031 

87,138 

Effect of dilutive stock units

-

-

-

-

Total weighted average shares outstanding - diluted

104,135 

103,665 

104,031 

87,138 

Diluted net loss per share

attributable to Frontier common shareholders

$

(3.31)

$

(4.11)

$

(55.26)

$

(6.09)

In calculating diluted net loss per common share for the three and nine months ended September 30, 2019 and 2018, the effect of all common stock equivalents is excluded from the computation as the effect would be antidilutive.

Stock Options

For the three and nine months ended September 30, 2019 and 2018, previously granted options to purchase 1,344 shares issuable under employee compensation plans were excluded from the computation of diluted earnings (loss) per share (EPS) for those periods because the exercise prices were greater than the average market price of our common stock and, therefore, the effect would be antidilutive.

Stock Units

At September 30, 2019 and 2018, we had 339,544 and 299,827 stock units, respectively, issued under the Non-Employee Directors’ Deferred Fee Equity Plan (Deferred Fee Plan), the Non-Employee Directors’ Equity Incentive Plan (Directors’ Equity Plan), the 2013 Equity Incentive Plan and the 2017 Equity Incentive Plan. These securities have not been included in the diluted EPS calculation for the three and nine months ended September 30, 2019 and 2018 because their inclusion would have an antidilutive effect. Compensation costs associated with the issuance of stock units were $0 and $1 million for the nine months ended September 30, 2019 and 2018, respectively.